JP2024515443A5 - - Google Patents

Info

Publication number
JP2024515443A5
JP2024515443A5 JP2023556942A JP2023556942A JP2024515443A5 JP 2024515443 A5 JP2024515443 A5 JP 2024515443A5 JP 2023556942 A JP2023556942 A JP 2023556942A JP 2023556942 A JP2023556942 A JP 2023556942A JP 2024515443 A5 JP2024515443 A5 JP 2024515443A5
Authority
JP
Japan
Prior art keywords
determines
detection
sample
ions
igf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023556942A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024515443A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/020906 external-priority patent/WO2022198020A1/en
Publication of JP2024515443A publication Critical patent/JP2024515443A/ja
Publication of JP2024515443A5 publication Critical patent/JP2024515443A5/ja
Pending legal-status Critical Current

Links

JP2023556942A 2021-03-19 2022-03-18 質量分析によるインスリン様増殖因子ｉバリアントの同定及び定量 Pending JP2024515443A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163163502P 2021-03-19 2021-03-19
US63/163,502 2021-03-19
PCT/US2022/020906 WO2022198020A1 (en) 2021-03-19 2022-03-18 Identification and quantitation of insulin-like growth factor-i variants by mass spectrometry

Publications (2)

Publication Number Publication Date
JP2024515443A JP2024515443A (ja) 2024-04-10
JP2024515443A5 true JP2024515443A5 (enExample) 2025-03-12

Family

ID=83284520

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023556942A Pending JP2024515443A (ja) 2021-03-19 2022-03-18 質量分析によるインスリン様増殖因子ｉバリアントの同定及び定量

Country Status (7)

Country Link
US (2) US12222354B2 (enExample)
EP (1) EP4308923A4 (enExample)
JP (1) JP2024515443A (enExample)
KR (1) KR20230169172A (enExample)
CN (1) CN117178188A (enExample)
CA (1) CA3212218A1 (enExample)
WO (1) WO2022198020A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117589998B (zh) * 2023-10-09 2025-11-18 融智生物科技（青岛）有限公司 胰岛素样生长因子i变体的定量检测试剂盒
CN117589997B (zh) * 2023-10-09 2025-11-21 融智生物科技（青岛）有限公司 Igf-1变体的定量检测方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080064044A9 (en) 1995-05-23 2008-03-13 Nelson Randall W Analysis of insulin-like growth factors from biological fluids by the use of affinity-based mass spectrometric methods
US20030027216A1 (en) * 2001-07-02 2003-02-06 Kiernan Urban A. Analysis of proteins from biological fluids using mass spectrometric immunoassay
WO2005101017A1 (en) * 2004-04-07 2005-10-27 Genentech, Inc. Mass spectrometry of antibody conjugates
EP1791551B1 (en) 2004-08-30 2020-02-26 Ipsen Biopharmaceuticals, Inc. Method and device for diagnosing and treating insulin-like growth factor deficiency disorders
EP1674113A1 (en) 2004-12-22 2006-06-28 F. Hoffmann-La Roche Ag Conjugates of insulin-like growth factor-1 (IGF-1) and poly(ethylene glycol)
ES2453108T3 (es) 2007-08-06 2014-04-04 Orion Genomics, Llc Nuevos polimorfismos de un único nucleótido y combinaciones de polimorfismos nuevos y conocidos para determinar la expresión específica de alelo del gen IGF2
EP2396429B1 (en) 2009-02-11 2015-05-27 Orion Genomics, LLC Combinations of polymorphisms for determining allele-specific expression of igf2
EP3095457B1 (en) 2009-11-05 2018-05-16 Quest Diagnostics Investments Incorporated Quantitation of insulin-like growth factor-i with high-resolution mass spectrometry
WO2015106224A2 (en) * 2014-01-12 2015-07-16 Hugh Mctavish Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses thereof
CN109957000B (zh) * 2017-12-14 2022-08-02 南开大学 一种促进细胞增殖的多肽衍生物及其制备方法及应用

Similar Documents

Publication Publication Date Title
WO2003087772A3 (en) Method for detecting low concentrations of a target bacterium that uses phages to infect target bacterial cells
US12253532B2 (en) Mass spectrometric quantitation assay for metabolites of leflunomide
CA2705930C (en) Identification of pathogens in body fluids by mass spectrometric measurements
JP5730878B2 (ja) 質量分析による分子の検出方法
Fagerquist et al. Genomic and proteomic identification of a DNA-binding protein used in the “fingerprinting” of Campylobacter species and strains by MALDI-TOF-MS protein biomarker analysis
US10011860B2 (en) Mass-spectrometric resistance determination by growth measurement
JP2005524394A5 (enExample)
JP2013513802A5 (enExample)
Colquhoun et al. Detection of norovirus capsid protein in authentic standards and in stool extracts by matrix-assisted laser desorption ionization and nanospray mass spectrometry
JP2018077253A5 (enExample)
WO2003065031A1 (en) Method and apparatus for analyzing amino acid, peptide, protein, saccharide or lipid
JP2015516579A (ja) 生物学的に関連性のある酸の選択的検知のための方法
JP2017516104A5 (enExample)
US20230274925A1 (en) Analysis method, adsorption prevention agent, and analysis kit
CN106324071B (zh) 细菌耐药蛋白ArmA的定性、定量检测方法
KR20120048012A (ko) 뉴모칸딘 화합물을 검출하는 방법
JP4188229B2 (ja) 細胞内に存在するタンパク質又は当該タンパク質と相互作用する物質を分析する方法
US20230236189A1 (en) Microbial Identification and Quantitation Using MS Cleavable Tags
Drake et al. Improved detection of intact tyrosine sulfate-containing peptides by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry in linear negative ion mode
JP2004198123A (ja) 分取液体クロマトグラフ質量分析装置
Sangubotla et al. Advances in mass spectrometry for microbial proteome analysis
US12630519B2 (en) Methods and systems for measuring ascorbic acid
CA3110921C (en) Methods and systems for measuring ascorbic acid
Rani et al. by LC-MS/MS MRM
WO2024005121A1 (ja) 較正方法、分析方法、制御装置および分析装置